Document is current
Any future updates will be listed below
-
Authors
de Vries, Esther https://orcid.org/0000-0002-1258-9989
Bakker, Elisabeth https://orcid.org/0000-0002-3359-9588
Francisca, Remy D. C. https://orcid.org/0000-0002-4382-7265
Croonen, Stijn
Denig, Petra https://orcid.org/0000-0002-7929-4739
Mol, Peter G. M. https://orcid.org/0000-0002-4262-3180
-
Funding
Funding for this research was provided by:
College ter Beoordeling van Geneesmiddelen
- License Information
-
More Information
Article History
Accepted: 23 January 2022
First Online: 29 March 2022
Declarations
:
: Informed consent was obtained from all individual participants included in the study.
: Consent for publication was not required since all responses were anonymous.
: The coding generated during the current study are available from the corresponding author on reasonable request.
: Study conception and design of the focus groups were performed by EV, PD and PGMM. Study conception and design of the survey were performed by EV, EB, PD and PGMM. Material preparation, data collection and analysis were performed by EV, RDCF, SC, EB, PD and PGMM. The first draft of the manuscript was written by EV and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
: Prior to the commencement of this study, details of the research were entered into the University Medical Center Groningen’s Research Register (UTOPIA study number 201800569) and it was determined that the study did not fall within the reach of the Dutch research involving human subjects act (WMO) and ethics approval was thus not required for the study. For this non-WMO study, the METc will not conduct any further assessment. Written informed consent was collected from all participants in the focus groups and respondents in the survey.
: Petra Denig, Stijn Croonen and Elisabeth Bakker have no conflicts of interest that are directly relevant to the content of this study. Esther de Vries, Remy Francisca, Peter G.M. Mol are (part-time) employees of the Dutch Medicines Evaluation Board. Any opinions, conclusions and proposals in the text are those of the authors and do not necessarily represent the views of the Dutch Medicines Evaluation Board.
: No specific funding for this study was obtained. Esther de Vries is performing a part-time PhD study program that is supported by the Dutch Medicines Evaluation Board. Funding was provided by College ter Beoordeling van Geneesmiddelen.
: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
